Hussein Mohamed Elhusseiny Ali Elbayoumi
Lecturer
Smart/stimuli-responsive chitosan/gelatin and other polymeric macromolecules natural hydrogels vs. synthetic hydrogels systems for brain tissue engineering: A state-of-the-art review
International Journal of Biological Macromolecules • 2024
Publication Information
Authors
Hussein M El-Husseiny, Eman A Mady, Ahmed S Doghish, Moataz B Zewail, Amr M Abdelfatah, Mina Noshy, Osama A Mohammed, Walaa A El-Dakroury
Keywords
Chitosan
Stimuli-responsive hydrogels
Brain tissue engineering
Journal
International Journal of Biological Macromolecules
Publisher
Elsevier
Volume
260
Issue
Part 1
Pages
129323
publication.type
International
Paper Link
Open Link
Supplementary Materials
Not Available
Abstract
Currently, there are no viable curative treatments that can enhance the central nervous system's (CNS) recovery from trauma or illness. Bioengineered injectable smart/stimuli-responsive hydrogels (SSRHs) that mirror the intricacy of the CNS milieu and architecture have been suggested as a way to get around these restrictions in combination with medication and cell therapy. Additionally, the right biophysical and pharmacological stimuli are required to boost meaningful CNS regeneration. Recent research has focused heavily on developing SSRHs as cutting-edge delivery systems that can direct the regeneration of brain tissue. In the present article, we have discussed the pathology of brain injuries, and the applicable strategies employed to regenerate the brain tissues. Moreover, the most promising SSRHs for neural tissue engineering (TE) including alginate (Alg.), hyaluronic acid (HA), chitosan (CH), gelatin, and collagen are used in natural polymer-based hydrogels and thoroughly discussed in this review. The ability of these hydrogels to distribute bioactive substances or cells in response to internal and external stimuli is highlighted with particular attention. In addition, this article provides a summary of the most cutting-edge techniques for CNS recovery employing SSRHs for several neurodegenerative diseases.
